Research progress and future of red blood cell substitutes

Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 8

Abstract

This paper briefly reviewed blood substitutes, focusing on the background, history of research and development(R&D), types, functions, characteristics, the indications that will be mainly targeted in clinical, and their special status and role in the future, especially in the rescue of war/trauma patients using hemoglobin-based oxygen carriers(HBOCs). Additionally, the authors put forward unique insights and suggestions on some key concepts and R&D bottlenecks in the development of HBOCs through combining the authors′ own R&D experience for decades with efforts and lessons given by many scholars in this field at home and abroad, hoping to provide some new inspirations and ideas for colleagues to innovate and develop blood substitutes to benefit the clinical as soon as possible.

Authors and Affiliations

Jiaxin LIU, Chengmin YANG

Keywords

Related Articles

Hepatitis E virus prevalence among blood donors in Wuhan

Objective To investigate the prevalence and risk factor of hepatitis E virus(HEV) infection among blood donors in Wuhan. Methods A total of 1 302 serum samples (including 1 076 with normal ALT and 226 with elevated ALT)...

HBsAg non-reactive but HBV DNA reactive blood donors in Wuhu area: infection status and tracing results

Objective To detect and analyze the infection status of HBsAg non-reactive /HBV DNA reactive blood donors by individual donor-NAT (ID-NAT) and chemiluminescence technology, and to explore the feasibility and potential ri...

The impact of massive intraoperative RBC transfusion on laboratory results and prognosis in patients underwent surgery for malignancies

Objective To explore the effects of massive intraoperative RBC transfusion on multiple clinical test indicators and prognosis of patients, underwent tumor surgery in order to provide evidence for rational blood transfusi...

Analysis of ABO system hemolytic disease of the fetus and newborn in 1 040 cases and its influencing factors

Objective To analyze ABO system hemolytic disease of the fetus and newborn (HDFN) and its influencing factors in Obstetrics Department of our hospital. Methods The blood samples of 1 040 neonates and their mothers in the...

Investigation on whole blood collection in Tianjin after fully lifting COVID-19 prevention and control measures

Objective To investigate the situation of whole blood collection in Tianjin after COVID-19 prevention and control measures were fully lifted. Methods The relevant data on whole blood collection of voluntary blood donors...

Download PDF file
  • EP ID EP738309
  • DOI 10.13303/j.cjbt.issn.1004-549x.2022.08.002
  • Views 37
  • Downloads 0

How To Cite

Jiaxin LIU, Chengmin YANG (2022). Research progress and future of red blood cell substitutes. Chinese Journal of Blood Transfusion, 35(8), -. https://europub.co.uk/articles/-A-738309